(Q40544063)

21 September 2017

1 reference

title

The inclusion of women in clinical trials of antihypertensive medications: a review of twenty-four trials in one pharmacology journal (English)

1 reference

21 September 2017

Nunnelee JD

1

1 reference

21 September 2017

publication date

1 June 1995

1 reference

Journal of Vascular Nursing

21 September 2017

published in

1 reference

21 September 2017

volume

13

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

41-49

1 reference

Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Hypertension in women

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Exclusion of certain groups from clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Intrinsic effect of antihypertensive treatment with isradipine and metoprolol on large artery geometric and elastic properties.

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

The effects of age and gender on the stereoselective pharmacokinetics of verapamil

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Pharmacodynamic modeling of the antihypertensive response to amlodipine

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

The influence of dose and ethnic origins on the pharmacokinetics of nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

The hypotensive action of captopril and enalapril is not prostacyclin dependent.

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Efficacy and tolerability of the renin inhibitor Ro 42-5892 in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Beta-adrenergic responsiveness is regulated selectively in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Quinidine interaction with nifedipine and felodipine: pharmacokinetic and pharmacodynamic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Decreased angiotensin II response but unaltered cardiovascular pressor response to infused norepinephrine after sodium restriction and converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Perindopril as monotherapy in hypertension: a multicenter comparison of two dosing regimens. The Perindopril Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Hemodynamics, biochemical effects, and pharmacokinetics of the renin inhibitor remikiren in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Antihypertensive mechanism of amlodipine in essential hypertension: role of pressor reactivity to norepinephrine and angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Differential effects of two dihydropyridine calcium antagonists in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Hemodynamic and humoral effects of the novel calcium antagonist Ro 40-5967 in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

The effects of rilmenidine on tests of autonomic function in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Dose responses and pharmacokinetics for the angiotensin converting enzyme inhibitor quinapril

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Systemic and regional hemodynamic effects of zabicipril in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Influence of time of administration on verapamil pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Racemic (R,S)-propranolol versus half-dosed optically pure (S)-propranolol in humans at steady state: Hemodynamic effects, plasma concentrations, and influence on thyroid hormone levels

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Age and β-adrenergic receptor sensitivity to S(−)- and R,S(±)-propranolol in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

Effects of celiprolol on cardiovascular reactivity to laboratory stressors in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1062-0303%2805%2980017-2

7 January 2021

10.1016/S1062-0303(05)80017-2

Identifiers

DOI

1 reference

21 September 2017

1 reference